Literature DB >> 15026021

Detection of O-acetylated Vi polysaccharide of Salmonella enterica subspecies typhi by enzyme immunoassay.

Sjoerd Rijpkema1, Zarmina Durrani, Xavier Lemercinier, Christopher Jones.   

Abstract

Immunisation with capsular Vi polysaccharide (Vi PS) of Salmonella enterica serovar Typhi (S. typhi) protects against typhoid. This protection depends on the presence of O-acetyl groups on the Vi PS, which form an immunodominant epitope. An antiserum raised against conjugated Vi PS was used as the basis for an indirect Enzyme Immunoassay (EIA). The antiserum did not react with lipopolysaccharide of five gram negative bacteria including S. typhi. Vi PS from three different sources was tested, and all but one of 18 native Vi PS preparations had EIA values comparable to a standard Vi PS preparation. The sensitivity of the EIA for the detection of O-acetyl groups on Vi PS was compared to an NMR spectroscopy assay (Biologicals 28 (2000) 17-24). The EIA distinguished between O-acetylated and de-O-acetylated Vi PS preparations. However, significantly lower EIA reactivity was observed only for samples which had O-acetylation levels of 25% or less. This assay should facilitate batch control of Vi vaccines.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15026021     DOI: 10.1016/j.biologicals.2003.09.002

Source DB:  PubMed          Journal:  Biologicals        ISSN: 1045-1056            Impact factor:   1.856


  3 in total

1.  Development of a synthetic Vi polysaccharide vaccine for typhoid fever.

Authors:  Yawei Ni; Michael J Springer; Jianhua Guo; Isaac Finger-Baker; James P Wilson; Ronald R Cobb; Debra Turner; Ian Tizard
Journal:  Vaccine       Date:  2017-11-14       Impact factor: 3.641

2.  O-acetylation of typhoid capsular polysaccharide confers polysaccharide rigidity and immunodominance by masking additional epitopes.

Authors:  Krisztina Hitri; Michelle M Kuttel; Gianluigi De Benedetto; Kay Lockyer; Fang Gao; Peter Hansal; Timothy R Rudd; Emma Beamish; Sjoerd Rijpkema; Neil Ravenscroft; Barbara Bolgiano
Journal:  Vaccine       Date:  2019-05-31       Impact factor: 3.641

3.  Establishment of the first International Standard for human anti-typhoid capsular Vi polysaccharide IgG.

Authors:  Sjoerd Rijpkema; Jason Hockley; Alastair Logan; Peter Rigsby; Eleanor Atkinson; Celina Jin; David Goldblatt; Haoyu Liang; Novilia S Bachtiar; Jae Seung Yang; Akshay Goel; Venkatesan Ramasamy; Marcela F Pasetti; Andrew J Pollard
Journal:  Biologicals       Date:  2018-09-07       Impact factor: 1.856

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.